Old Web
English
Sign In
Acemap
>
Paper
>
P468 Switching from adalimumab originator to ABP 501 biosimilar: a multicentre North Italian study
P468 Switching from adalimumab originator to ABP 501 biosimilar: a multicentre North Italian study
2020
Brigida Barberio
P Melatti
Fabiana Zingone
L Bertani
Antonio Ferronato
A Gubbiotti
Davide Massimi
Renata D’Incà
Edoardo Savarino
Keywords:
Physical therapy
Adalimumab
Internal medicine
Medicine
Biosimilar
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI
[]